Cancer-related fatigue: An update

被引：27

作者：

Sood A. ^{[1
]}

Moynihan T.J. ^{[1
]}

机构：

[1] Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905

来源：

Current Oncology Reports | 2005年 / 7卷 / 4期

关键词：

Clin Oncol; Methylphenidate; National Comprehensive Cancer Network; National Comprehensive Cancer Network; Modafinil;

D O I：

10.1007/s11912-005-0051-8

中图分类号：

学科分类号：

摘要：

Fatigue, one of the most common symptoms experienced by cancer patients, is multidimensional and is associated with significant impairment in functioning and overall quality of life. Although the precise pathophysiology of cancer-related fatigue is not well understood, a number of metabolic, cytokine, neurophysiologic, and endocrine changes have been described in these patients. A better understanding of these abnormalities is likely to lead to novel therapeutic interventions. Clinically, all patients presenting with significant fatigue should be evaluated for treatable conditions that might contribute to this symptom. Exercise and treatment of anemia are the two most established interventions for cancer-related fatigue. Psychostimulants seem promising based on early studies. Several complementary medicine treatments that showed efficacy in preliminary studies merit further testing. Copyright © 2005 by Current Science Inc.

引用

页码：277 / 282

页数：5

共 66 条

[1]

Probability of developing cancer, NCI 2003

[2]

Mock V., Atkinson A., Barsevick A., Et al., NCCN practice guidelines for cancer-related fatigue, Oncology (Huntingt.), 14, pp. 151-161, (2000)

[3]

Portenoy R.K., Itri L.M., Cancer-related fatigue: Guidelines for evaluation and management, Oncologist, 4, pp. 1-10, (1999)

[4]

Curt G.A., The impact of fatigue on patients with cancer: Overview of FATIGUE 1 and 2, Oncologist, 2, SUPPL., pp. 9-12, (2000)

[5]

Okuyama T., Akechi T., Kugaya A., Et al., Factors correlated with fatigue in disease-free breast cancer patients: Application of the Cancer Fatigue Scale, Support Care Cancer, 8, pp. 215-222, (2000)

[6]

Cella D., Davis K., Breitbart W., Curt G., Cancer-related fatigue: Prevalence of proposed diagnostic criteria in a United States sample of cancer survivors, J. Clin. Oncol., 19, pp. 3385-3391, (2001)

[7]

de Jong N., Candel M.J., Schouten H.C., Et al., Prevalence and course of fatigue in breast cancer patients receiving adjuvant chemotherapy, Ann. Oncol., 15, pp. 896-905, (2004)

[8]

Curt G.A., Breitbart W., Cella D., Et al., Impact of cancer-related fatigue on the lives of patients: New findings from the Fatigue Coalition, Oncologist, 5, pp. 353-360, (2000)

[9]

Jacobsen P.B., Stein K., Is fatigue a long-term side effect of breast cancer treatment?, Cancer Control, 6, pp. 256-263, (1999)

[10]

Vogelzang N.J., Breitbart W., Cella D., Et al., Patient, caregiver, and oncologist perceptions of cancer-related fatigue: Results of a tripart assessment survey. The Fatigue Coalition, Semin. Hematol., 34, pp. 4-12, (1997)

← 1 2 3 4 5 6 7 →